![]() |
|
|
Vol. 290, Issue 1, 129-135, July 1999
Department of Pharmacology, Texas Tech University Health Sciences
Center, Lubbock, Texas
The widely used calcium channel antagonist
3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester (TMB-8) has
been identified as a noncompetitive antagonist (NCA) and open-channel
blocker of both muscle- and neuronal-type nicotinic acetylcholine
receptors (AChRs). To further examine the interaction of TMB-8 with the AChR, the compound was tested as a competitor for the binding of two
NCAs of the Torpedo californica AChR, phencyclidine and 3-trifluoromethyl-3-(m[125I]iodophenyl)diazirine,
for which the binding to the AChR has been pharmacologically well
characterized and a channel binding loci has been established. TMB-8
fully inhibited specific photoincorporation of
3-trifluoromethyl-3-(m[125I]iodophenyl)diazirine
into the resting AChR channel (IC50 = 3.1 µM) and
inhibited high-affinity [3H]phencyclidine binding to the
desensitized AChR (IC50 = 2.4 µM). We conclude that
TMB-8 is a potent NCA of the nicotinic AChR, interacting with the
resting, open-channel, and desensitized channel conformations. TMB-8
was next tested as an inhibitor of the structurally homologous
5-hydroxytryptamine (5-HT)3 receptor (5-HT3R).
Using 5-HT3R containing Sf21 cell membranes, TMB-8
completely inhibited specific binding of the radiolabeled
5-HT3R antagonist [3H]GR65630
(Ki = 2.5 µM). Furthermore, TMB-8
antagonized 5-HT-evoked currents of both mouse and human
5-HT3Rs expressed in Xenopus laevis oocytes,
and additional analysis was consistent with a competitive antagonistic
mechanism of action. These results, taken together, indicate that TMB-8
antagonizes the function of the AChR and 5-HT3R by
different mechanisms. Given the sequence similarity and emerging
evidence of structural homology in the channels of these two receptors,
these results underscore the existence of subtle yet important
structural differences in each channel.
This article has been cited by other articles:
![]() |
T. K. Machu, M. E. Hamilton, T. F. Frye, C. L. Shanklin, M. C. Harris, H. Sun, T. E. Tenner Jr., F. S. Soti, and W. R. Kem Benzylidene Analogs of Anabaseine Display Partial Agonist and Antagonist Properties at the Mouse 5-Hydroxytryptamine3A Receptor J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1112 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Arias, E. A. McCardy, and M. P. Blanton Characterization of the Dizocilpine Binding Site on the Nicotinic Acetylcholine Receptor Mol. Pharmacol., April 16, 2001; 59(5): 1051 - 1060. [Abstract] [Full Text] |
||||
![]() |
H. Dang, P. M. England, S. S. Farivar, D. A. Dougherty, and H. A. Lester Probing the Role of a Conserved M1 Proline Residue in 5-Hydroxytryptamine3 Receptor Gating Mol. Pharmacol., June 1, 2000; 57(6): 1114 - 1122. [Abstract] [Full Text] |
||||